Efficacy and safety of Nuwiq®(human-cl rhFVIII) in patients with severe haemophilia A undergoing surgical procedures-Reference-Cited by-同舟云学术

Efficacy and safety of Nuwiq®(human-cl rhFVIII) in patients with severe haemophilia A undergoing surgical procedures

Published:2017-10-19 Issue:1 Volume:24 Page:70-76
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Zozulya N.¹,Kessler C. M.²,Klukowska A.³,von Depka M.⁴,Hampton K.⁵^ORCID,Hay C. R. M.⁶^ORCID,Jansen M.⁷,Bichler J.⁸,Knaub S.⁸,Rangarajan S.⁹

Affiliation:

1. Federal State-Funded Institution “National Research Center for Hematology” of the Ministry of Healthcare of the Russian Federation; Moscow Russia

2. Division of Coagulation; Hemophilia and Thrombosis Comprehensive Treatment Center; Georgetown University Medical Center; Washington DC USA

3. Department of Pediatrics, Hematology and Oncology; Warsaw Medical University; Warsaw Poland

4. Werlhof-Institut für Hämostaseologie GmbH; Hannover Germany

5. Royal Hallamshire Hospital; Sheffield UK

6. Department of Haematology; Manchester University; Manchester Royal Infirmary; Manchester UK

7. Octapharma Pharmazeutika Produktionsges.mbH; Vienna Austria

8. Octapharma AG; Lachen Switzerland

9. Basingstoke and North Hampshire Hospital; Basingstoke UK

Funder

Octapharma AG (Lachen, Switzerland)

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.13351/fullpdf

Reference21 articles.

1. Surgery in patients with inherited bleeding disorders;Mensah;Anaesthesia,2015

2. Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery;Coppola;Cochrane Database Syst Rev,2015

3. Surgical evaluation of a recombinant factor VIII prepared using a plasma/albumin-free method: efficacy and safety of Advate in previously treated patients;Négrier;Thromb Haemost,2008

4. Efficacy of a sucrose-formulated recombinant factor VIII used for 22 surgical procedures in patients with severe haemophilia A;Scharrer;Haemophilia,2000

5. Efficacy and safety of pegylated full-length recombinant factor VIII with extended half-life for perioperative haemostasis in haemophilia A patients;Brand;Haemophilia,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simoctocog alfa (Nuwiq^®) in children: early steps in life’s journey for people with severe hemophilia A;Therapeutic Advances in Hematology;2024-01

2. Perioperative Monitoring with Rotational Thromboelastometry in a Severe Hemophilia A Patient Undergoing Elective Ankle Surgery;Seminars in Thrombosis and Hemostasis;2023-04-19

3. Turoctocog alfa pegol provides effective management for major and minor surgical procedures in patients across all age groups with severe haemophilia A: Full data set from the pathfinder 3 and 5 phase III trials;Haemophilia;2020-04-15

4. Blood, blood components, plasma, and plasma products;Side Effects of Drugs Annual;2019

5. Efficacy and safety of simoctocog alfa (Nuwiq®) in patients with severe hemophilia A: a review of clinical trial data from the GENA program;Therapeutic Advances in Hematology;2019-01